THE CHISLEHURST PARTNERSHIP — All Prescriptions & Medications — Page 12
Practice Code: G84010 | CHISLEHURST, BR7 5AQ
Showing results 551-600 of 720
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 22 | 418 | £1.5K | -15.1% ▼ | |
| Rabeprazole sodium | 21 | 1,456 | £117 | -59.3% ▼ |
| Glyceryl trinitrate | 21 | 660 | £822 | +58.1% ▲ |
| Amiodarone hydrochloride | 21 | 1,064 | £57 | -67.4% ▼ |
| Bempedoic acid/Ezetimibe | 21 | 1,022 | £1.9K | -65.6% ▼ |
| Naratriptan hydrochloride | 21 | 372 | £73 | -19.7% ▼ |
| Brivaracetam | 21 | 4,988 | £5.0K | -38.3% ▼ |
| Itraconazole | 21 | 1,101 | £504 | +56.5% ▲ |
| Liothyronine sodium | 21 | 2,184 | £5.3K | -1.6% vs avg |
| Ferrous gluconate | 21 | 1,444 | £39 | -56.1% ▼ |
| Calcium acetate | 21 | 2,548 | £259 | +13.5% ▲ |
| 21 | 2,310 | £3.4K | +14.1% ▲ | |
| 21 | 21 | £379 | +144.5% ▲ | |
| 21 | 1,020 | £913 | -48.2% ▼ | |
| Sodium picosulfate | 20 | 4,760 | £417 | -44.9% ▼ |
| Sodium citrate (Rectal) | 20 | 244 | £160 | +44.9% ▲ |
| Enoxaparin | 20 | 454 | £1.5K | -2.4% ▼ |
| Dipyridamole | 20 | 1,620 | £338 | -22.1% ▼ |
| Bempedoic acid | 20 | 1,036 | £1.9K | -39.0% ▼ |
| Pyridostigmine bromide | 20 | 4,200 | £338 | +16.8% ▲ |
| Azelastine hydrochloride | 20 | 616 | £280 | +78.4% ▲ |
| Pimecrolimus | 20 | 720 | £445 | +18.1% ▲ |
| 20 | 99 | £631 | +25.0% ▲ | |
| 20 | 21 | £201 | +100.0% ▲ | |
| 20 | 57 | £874 | +161.5% ▲ | |
| 20 | 870 | £2.6K | +148.0% ▲ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 19 | 700 | £83 | -45.4% ▼ |
| Lofepramine hydrochloride | 19 | 2,100 | £892 | -36.5% ▼ |
| Hyoscine hydrobromide | 19 | 1,524 | £240 | -44.4% ▼ |
| Levodopa/carbidopa/entacapone | 19 | 4,200 | £2.8K | -32.1% ▼ |
| Dapagliflozin/metformin | 19 | 1,400 | £869 | -56.7% ▼ |
| Other compound vitamin/mineral formulation preparations | 19 | 1,060 | £91 | -40.7% ▼ |
| Azelastine hydrochloride | 19 | 160 | £122 | +59.8% ▲ |
| Crotamiton | 19 | 2,930 | £166 | +14.3% ▲ |
| 19 | 1,680 | £2.3K | +94.2% ▲ | |
| 19 | 430 | £295 | -42.1% ▼ | |
| 19 | 1,090 | £4.5K | -26.5% ▼ | |
| Nizatidine | 18 | 1,290 | £730 | -47.7% ▼ |
| Sennosides | 18 | 7,400 | £139 | -41.7% ▼ |
| Phosphates (Rectal) | 18 | 41 | £1.9K | +47.3% ▲ |
| Zinc oxide | 18 | 478 | £60 | -13.0% ▼ |
| Clonidine hydrochloride | 18 | 1,008 | £79 | -1.5% vs avg |
| Acrivastine | 18 | 1,598 | £467 | +46.1% ▲ |
| Zuclopenthixol hydrochloride | 18 | 1,800 | £176 | -42.9% ▼ |
| Cinnarizine | 18 | 1,887 | £85 | -61.5% ▼ |
| Insulin glulisine | 18 | 100 | £566 | -16.0% ▼ |
| Mercaptopurine | 18 | 861 | £402 | +16.2% ▲ |
| Tablets/capsules micronutrient supplement (0913282) | 18 | 1,080 | £753 | +71.9% ▲ |
| Leflunomide | 18 | 870 | £57 | -52.4% ▼ |
| Hydrocortisone acetate | 18 | 230 | £727 | +172.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.